Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics

Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics

Abstract Background To assess the drug survival and change of disease activity using a second Janus kinase inhibitor (JAKi) after failure to a JAKi and subsequent biologic disease-modifying anti-rheumatic drugs (bDMARDs) in patients with difficult-to-treat rheumatoid arthritis (RA). Methods This ret...

Full description

Bibliographic Details
Main Authors: Oh Chan Kwon, Wonho Choi, Soo Min Ahn, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Min-Chan Park, Yong-Gil Kim
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Advances in Rheumatology
Subjects:
Rheumatoid arthritis
Janus kinase inhibitor, switching
Drug survival
Effectiveness
Online Access:https://doi.org/10.1186/s42358-024-00368-w

Internet

https://doi.org/10.1186/s42358-024-00368-w

Similar Items